Find Grants for Municipalities, Political Subdivisions, and State Governments

Find out if you qualify for verified grants for Municipalities, Political Subdivisions, and State Governments . Discover your eligibility and key funding details for Municipalities, Political Subdivisions, and State Governments from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-202

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

Deadline: June 22, 2026


Opportunity Number: PAR-25-170

Agency: National Institutes of Health

Open Date: November 13, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.399, 93.853, 93.866

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-167

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.393

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Deadline: September 7, 2028


Opportunity Number: PA-25-253

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: September 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-027

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-081

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393, 93.399, 93.394, 93.395

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-136

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PA-25-172

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)

Deadline: March 6, 2026


Opportunity Number: PAR-25-049

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: March 6, 2026

Status: Posted

CFDA Numbers: 93.853

NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-234

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.853

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-079

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.395, 93.394

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-063

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.242

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-153

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.395

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Deadline: September 7, 2027


Opportunity Number: PAR-24-325

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-145

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Deadline: May 7, 2026


Opportunity Number: PAR-25-036

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-175

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.395, 93.394

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-24-311

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.395, 93.396

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-24-321

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.866

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-227

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-221

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.396, 93.273

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-24-306

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.393, 93.395, 93.396, 93.394

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Deadline: January 6, 2028


Opportunity Number: PAS-25-205

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.839, 93.847, 93.866

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: September 28, 2026


Opportunity Number: RFA-NS-25-021

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: September 28, 2026

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.242, 93.213, 93.865, 93.173, 93.853, 93.286, 93.273, 93.279

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

Deadline: September 28, 2026


Opportunity Number: RFA-NS-25-022

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: September 28, 2026

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.286, 93.279, 93.865, 93.853, 93.273, 93.173, 93.213, 93.242

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.